Do immunoinflammatory biomarkers predict CHD risk in NAFLD patients?
The NHR index and other immunoinflammatory biomarkers show promise in predicting coronary heart disease risk among patients with non-alcoholic fatty liver disease.
Six immunoinflammatory markers demonstrated significant associations with CHD risk in NAFLD populations, among which the NHR index exhibited particularly promising predictive potential.
Dong et al. (Thu,) studied this question.